Market Place
Sourcing Support
Touchlight, University of Nottingham Partner to Develop Zika DNA Vaccine
21 Aug 2024 //
PRESS RELEASE
Touchlight, GSK Enter License Agreement
23 Jul 2024 //
PRESS RELEASE
Touchlight and LeninBio announce link up
02 Jul 2024 //
PRESS RELEASE
Touchlight And NPL Get Grant For Novel Gene-Length Editing Template
09 May 2024 //
PRESS RELEASE
Touchlight Receives Grant Extension For DNA-Enabled Biobatteries Research
26 Apr 2024 //
PRESS RELEASE
Touchlight Wins Business Innovator Award At SAP UKI Customer Success 2024
16 Apr 2024 //
PRESS RELEASE
Touchlight joins forces with University of Liverpool for NSCLC vaccine
03 Apr 2024 //
PRESS RELEASE
Touchlight To Supply Enzymatic dbDNA To CPI`s RNA Centre Of Excellence
28 Mar 2024 //
PRESS RELEASE
Touchlight’s enzymatic doggybone DNA used in manufacture of Versameb’s VMB-100
21 Nov 2023 //
BUSINESSWIRE
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
25 Jul 2023 //
PRESS RELEASE
Touchlight launches its new customer offering of Discovery grade doggybone DNA (dbDNA)
12 Jul 2023 //
PRESS RELEASE
Touchlight Completes Expansion, Creating One of the World’s Largest DNA
24 May 2023 //
BUSINESSWIRE
Touchlight and 20Med partner on vaccine platform
19 Apr 2023 //
PHARMA TIMES
Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing
29 Mar 2023 //
PRESS RELEASE
Touchlight Cleared by FDA for IND Utilizing Doggybone DNA
28 Feb 2023 //
CONTRACT PHARMA
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight’s Enzymatic doggybone DNA Technology
24 Jan 2023 //
BUSINESSWIRE
Touchlight and Odimma enter cancer therapy clinical material supply agreement
08 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement
07 Dec 2022 //
BUSINESSWIRE
Touchlight receives funding to develeop DNA vaccine platform
29 Nov 2022 //
PHARMATIMES
Touchlight receives grant to advance thermostable doggybone DNA vaccine platform
28 Nov 2022 //
BUSINESSWIRE
Touchlight signs license agreement with Voyager for use of DNA technology
25 Nov 2022 //
PRESS RELEASE
Lonza, Touchlight partner on `doggybone DNA` development
06 Sep 2022 //
FIERCE PHARMA
Touchlight Signs Patent License Agreement With Pfizer
06 Jul 2022 //
PRESS RELEASE
Touchlight signs supply agreement for Versameb`s pipeline
07 Mar 2022 //
ENDPTS
Touchlight and Versameb Enter Development & Manufacturing Pipeline Agreement
01 Mar 2022 //
PRESS RELEASE
Bayer-owned AskBio will shift focus toward DNA in restructure with Touchlight
10 Feb 2022 //
ENDPTS
Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50
22 Nov 2021 //
PRESS RELEASE
Touchlight expands commercial team amid rapid company growth
21 Oct 2021 //
PRESS RELEASE
Touchlight to break ground on world’s highest-capacity DNA manufacturing facility
15 Oct 2021 //
PRESS RELEASE
Touchlight doubles fundraising this year with latest round of private backers
16 Sep 2021 //
ENDPTS
Touchlight and Vanderbilt University Medical Center collaborate on DARPA Pandemic Prevention Platform programme
28 Jul 2021 //
PRESS RELEASE
DNA production specialist Touchlight raises £42m
10 Mar 2021 //
PHARMATIMES
Synthetic DNA player Touchlight scores $60M round to more than triple
10 Mar 2021 //
ENDPTS
DNA maker Touchlight adds Lonza veteran to head manufacturing
15 Oct 2020 //
FIERCE PHARMA
Cancer Research UK, University of Southampton and Touchlight Genetics Partner
29 Jul 2020 //
DRUGDISCOVERY
